Deutsche Bank’s Nutex Health NUTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$369K Buy
3,883
+1,250
+47% +$153K ﹤0.01% 2729
2025
Q4
$433K Buy
2,633
+98
+4% +$13K ﹤0.01% 2647
2025
Q3
$262K Buy
2,535
+301
+13% +$29.5K ﹤0.01% 2923
2025
Q2
$278K Buy
+2,234
New +$289K ﹤0.01% 2776
2023
Q3
Sell
-71
Closed -$4.48K 3787
2023
Q2
$4.48K Sell
71
-1,016
-93% -$87.1K ﹤0.01% 3702
2023
Q1
$165K Buy
1,087
+312
+40% +$63.2K ﹤0.01% 3096
2022
Q4
$221K Buy
775
+658
+562% +$126K ﹤0.01% 2926
2022
Q3
$27K Sell
117
-17
-13% -$7.21K ﹤0.01% 3725
2022
Q2
$65K Buy
+134
New +$158K ﹤0.01% 3681

Other funds holding NUTX

Deutsche Bank's NUTX Position: Q1 2026 in Review

Deutsche Bank increased its Nutex Health (NUTX) stake by 47% in Q1 2026, buying an estimated $153K and bringing the position to 3,883 shares worth $369K. The position accounts for ﹤0.01% of the portfolio, ranked #2729.

Deutsche Bank first reported a position in NUTX in Q2 2022 and has held it in 9 quarters since. The position peaked at $433K in Q4 2025. 129 funds tracked by Wall St. Rank hold NUTX as of Q1 2026.

  • Deutsche Bank held 3,883 shares of Nutex Health worth $369K as of Q1 2026.
  • Deutsche Bank bought 1,250 Nutex Health shares in Q1 2026, an estimated $153K.
  • Nutex Health made up ﹤0.01% of Deutsche Bank's portfolio in Q1 2026, its #2729 holding.
  • Deutsche Bank first reported a position in Nutex Health in Q2 2022 and has held it in 9 quarters since.
  • Deutsche Bank's Nutex Health position peaked at $433K in Q4 2025.
  • 129 funds tracked by Wall St. Rank held Nutex Health as of Q1 2026.

Based on Deutsche Bank's 13F filing for Q1 2026, filed 6 May 2026.